Olamkicept

Names

[ CAS No. ]:
1702282-14-1

[ Name ]:
Olamkicept

Biological Activity

[Description]:

Olamkicept (FE 999301) is a selective inhibitor of the soluble interleukin 6 (sIL-6R)/IL-6 complex. Olamkicept is a soluble gp130-Fc-fusion-protein and anti-inflammatory agent[1][2].

[Related Catalog]:

Signaling Pathways >> Immunology/Inflammation >> Interleukin Related
Research Areas >> Inflammation/Immunology

[Target]

sIL-6R/IL-6 Complex[1]


[In Vitro]

Olamkicept (10 µg/mL，60 分钟) 抑制 HREC 中 IL-6 转信号介导的 STAT3 激活[5]。 Olamkicept (10 µg/mL，60 分钟) 抑制 IL-6 转导信号诱导的 HREC 中 H2O2 水平的增加[5]. Olamkicept (10 µg/mL，60 分钟) 抑制 IL-6 转导诱导的 HREC 细胞凋亡[5]。 Olamkicept (0-1 µg/mL) 抑制 IL-11/重组 sIL-11R 诱导的 Ba/F3-gp130 细胞增殖[6]。 Western Blot Analysis[5] Cell Line: Human retinal endothelial cells (HRECs) Concentration: 10 µg/mL Incubation Time: 60 min Result: Inhibited IL-6/sIL-6R induced increase in STAT3 phosphorylation.

[In Vivo]

Olamkicept (sgp130Fc) (0.01-10 mg/kg，皮下注射) 提高盲肠结扎穿孔 (CLP) 败血症小鼠模型的存活率[3]。 Olamkicept (0.5 mg/kg，腹腔注射) 抑制盲肠结扎穿孔 (CLP) 诱导的败血症小鼠的炎症并提高存活率[4]。 Animal Model: Cecal ligation and puncture (CLP) sepsis mice model[3] Dosage: 0.01, 0.1, 1, 10 mg/kg Administration: s.c. Result: Improved survival rate and physical activity.

[References]

[1]. Schreiber S, et al. Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease. Gastroenterology. 2021 Jun;160(7):2354-2366.e11.  

[2]. Zhang S, et al. Effect of Induction Therapy With Olamkicept vs Placebo on Clinical Response in Patients With Active Ulcerative Colitis: A Randomized Clinical Trial. JAMA. 2023 Mar 7;329(9):725-734.  

[3]. Barkhausen T, et al. Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model. Crit Care Med. 2011 Jun;39(6):1407-13.  

[4]. SHI Dan-dan, et al. IL-6 trans-signaling inhibitor sgp130Fc suppresses inflammation and regulates immune cells in mice with sepsis. Basic & Clinical Medicine. 2022, 42 (12): 1895-1899.

[5]. Valle ML, et al. Inhibition of interleukin-6 trans-signaling prevents inflammation and endothelial barrier disruption in retinal endothelial cells. Exp Eye Res. 2019 Jan;178:27-36.  

[6]. Lokau J, et al. Proteolytic Cleavage Governs Interleukin-11 Trans-signaling. Cell Rep. 2016 Feb 23;14(7):1761-1773.  

Chemical & Physical Properties

No Any Chemical & Physical Properties

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.